Global Market for Bioinformatics to touch $2.4 billion in 2011

"According to the new market research report from Industry Experts ‘Bioinformatics – A Global Market Overview’, global market for bioinformatics is estimated at about $2.4 billion in 2011 and further projected to reach $7.6 billion by 2017 registering a CAGR of 18.3% during the period 2007-2017.

At the beginning of the “genomic revolution”, Bioinformatics was applied in creating and maintaining a database that stored biological information, such as nucleotide and amino acid sequences. Development of this type of database involved not only design issues but also the development of complex interfaces, whereby researchers could access existing data, in addition to submitting new or revised data.

Market for Bioinformatics product categories analyzed in this study includes Bioinformatics Content, Bioinformatics Analysis Software & Services and Bioinformatics IT Infrastructure & Other Services. The report also includes the market analysis for end-use application analysis of Bioinformatics – Biopharma & Diagnostics, Genomics, Agriculture, Chemicals and Environmental & Other."

more details

Strong Investments to Boost Global Bioinformatics Market

According to our latest report entitled “Global Bioinformatics Market Outlook”, the global bioinformatics industry has been witnessing a remarkable growth rate pattern for the past few years. Factors, such as increasing R&D investments by companies and regulatory support boosted the market revenue to reach around US$ 2.6 Billion in 2009. As the bioinformatics market is at the nascent stage, its full potential is yet to be exploited. Moreover, there are significant advances in technologies that will boost the bioinformatics industry in future. It is expected that the market will grow at a CAGR of nearly 26% during 2011-2013 to reach US$ 6.2 Billion.

Our report has found that the escalating importance of personalized medicines has significantly augmented the growth level in proteomics market. Rising awareness of protein research and its study has opened the market for different proteomic-related equipments, technologies, and services. It is estimated that by 2013, the proteomics market will be worth around US$ 17 Billion and it will act as an important contributor in the growth of bioinformatics.

more

Global Biotechnology Instrumentation Market to Reach US$5.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

Biotechnology Instrumentation sector continues to display healthy growth supported by biotech research expansion in pharmaceutical operations, forensics, agriculture environmental monitoring, and animal husbandry sectors. Demand for faster and economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics and combinatorial chemistry have led to the advancements of bioinstrumentation in recent years. The use of bioinstrumentation techniques has become simple and more accessible. The routine biological tests in forensic laboratories and food technology facilities are performed by instruments such as off-the-shelf kits of PCR primers, automated analytical equipment, and automated synthesizers.

Universities, particularly medical schools, are the largest end-users of biotech instruments. Product enhancements, such as automation and better reproducibility, have led to an increased demand from pharmaceutical companies. Emerging sectors in drug discovery arena such as genomics, proteomics, DNA chips, combinatorial chemistry, and high throughput screening, are fueling the demand for bioinstrumentation by the life science industry. Rapid advancements in biotechnology and pharmaceutical research require complicated analysis and purification methods. An unprecedented interest in these fields led to a significant increase in the use of analytical techniques such as HPLC, Gas Chromatography, and Mass Spectrometry.

more ...

Global Bioinformatics Market to Reach US$5.0 Billion by 2015

Bioinformatics, one of the most vibrant industries in the current scenario, is at the forefront of the biotech revolution. The market is projected to transform into a major industry within the next few years. Driving the revolution is genomics, a set of advanced tools designed for large data acquisition and analysis. New tools are not only pushing the development of drug discovery, but also fundamentally changing the nature of biological research. The success of Human Genome Project and breakthrough technologies in drug discovery initiatives spells significant investment opportunities for the industry. As new players enter the market, and existing companies grow in size and revenue, competition in the bioinformatics industry is likely to intensify significantly.
Globally, pharmaceutical companies are increasingly seeking help from biotechnology to alleviate concerns related to increasing number of blockbuster drugs going off-patent, narrow product pipelines, and high drug development costs. Bioinformatics can be applied in every stage of the R&D processes in biotechnology as well as the pharmaceutical sectors. The emergence of genomics and its ever-growing application in the research and development processes have created soaring amount of data, creating significant opportunities for bioinformatics. Data management tools based on bioinformatics have helped companies in easing the task of R&D analysis, thereby enhancing their productivity by way of identifying new biomarkers for toxicity and drug efficacy, diagnostic biomarkers as well as new drug targets. Bioinformatics help utilization of the gene and protein data and construct interactive models that aid in identifying disease pathways and effects of compounds.
Going forwards, the penetration of genomics in drug discovery is expected to increase further, which bodes tremendous market prospects for bioinformatics. In addition, more and more spending is expected to be made in research and development from pharmaceutical companies, of which a major chunk is expected to end up in the area of bioinformatics. Bioinformatics is a multifaceted market, characterized by a host of licensing and research and development collaborations. Worldwide bioinformatics market is primarily concentrated in the United States and Europe. The industry represents one of the fastest growing fields offering economic opportunities in various areas.
The US represents the largest regional market for bioinformatics worldwide, followed by Europe, as stated by the new market research report on Bioinformatics. However, Asia-Pacific is projected to record the fastest growth over the analysis period. Japanese market is projected to post a CAGR of 13.5% during the analysis period. Segment wise, Biocontent represents the largest product segment in the global bioinformatics market. Bioinformatics Software represents the fastest growing product segment. Demand for Bioinformatics hardware is projected to rise by 9.5% during the analysis period.
The global bioinformatics industry is highly fragmented, with several companies offering only specific services and a very few companies delivering comprehensive solutions for their clients' R&D needs. Large-scale presence of smaller companies and high fragmentation is due to lower entry barriers and existence of large IT companies in the sector. Major players profiled in the report include 3rd Millennium, Inc, Accelrys, Inc., Affymetrix, Agilent Technologies, BioWisdom Ltd, Celera Group, Gene Logic, IBM Life Sciences, Life Technologies Corporation, and Rosetta Inpharmatics.
The research report titled "Bioinformatics: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the bioinformatics market, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for bioinformatics market for the years 2007 through 2015 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Key segments analyzed include Software (Bioinformatics), Biocontent (Bioinformatics), and Hardware (Bioinformatics). Also, a seven-year (2000-2006) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit -
www.strategyr.com/Bioinformatics_Market_Report.asp


Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2011/01/10/prweb8052230.DTL#ixzz1BJeau2Po

Canadian National Proteomics Network

Lately, I was invited to join Canadian National Proteomics Network. CNPN is a not-for-profit federally incorporated organization created to provide a cooperative mechanism for building the proteomics research infrastructure in Canada to further a better understanding of proteomics in the Canadian life sciences community and to sponsor scientific conferences, seminars and forums to create a national focus for scientific collaboration and education.


It is unclear how many members it has now, but I would guess it is a small group, mainly consists of students, postodocs and professors. Anyway, I hope it can really grow and create more communications, collaborations, and career opportunities for bioinformatics professionals. It is a crucial especially for a less populated country like Canada.


click here to see what is new.

Bioinformatics: Global Market Forecast Updated

The global market for bioinformatics will surge at a compound annual growth rate (CAGR) of nearly 26 percent during 2011-2013, according to market research and information analysis firm RNCOS.

The research firm said that bioinformatics offers an indispensable technology for function assignment and is widely used for gene annotation. Initial efforts in bioinformatics were focused on the analysis of DNA sequence data.

However, presently, the scope and objectives of bioinformatics research and development have broadened owing to the high generation of data from various sources and for different cellular processes, continuously evolving analytical technologies, and increasing computational capability.

The global bioinformatics industry has been witnessing double-digit growth rate for the past decade due to ongoing research. With increasing R&D investments by companies on bioinformatics and regulatory support by various countries, the research firm anticipate that the bioinformatics market will post high growth rate in majority of the countries.

The research firm found that the technology has its applications in a variety of areas, including genomics, proteomics, pharmacogenomics, and cheminformatics.

Bioinformatics companies collaborate with other companies or with research institutes to enhance their operations. Partners may share the resources such as, products, intellectual property, project funding, knowledge, expertise, manufacturing capability, and capital equipment, added the research firm.

This research report categorizes the global bioinformatics market into the following segments:

Bioinformatics platforms

• Sequence alignment platforms
• Sequence manipulation platforms
• Sequence analysis platforms
• Structural analysis platforms

Content/Knowledge management tools

• Specialized knowledge management tools
• Generalized knowledge management tools

Services

• Data Analysis
• Sequencing Services
• Database & Management services

Bionformatics market size report 2010: above 6B in 2013.

Below is an excerpt from Gobal Bioinformatics Market Outlook.
More Info: http://www.mindbranch.com/Global-Bioinformatics-Outlook-R459-1026/


Although the effects of recession looming large on different industries over the past year, the development and implementation of computational tools and frameworks for the management, analysis and interpretation of biological information remained the focal point of leading industrial players. Initial efforts in bioinformatics were focused on the analysis of DNA sequence data. Presently, the scope and objectives of bioinformatics research and development have broadened owing to the high generation of data from various sources and for different cellular processes, continuously evolving analytical technologies and the increasing computational capability.

As per our new research report “Global Bioinformatics Market Outlook”, the market for bioinformatics will surge at a CAGR of nearly 26% during 2011-2013 to a value of around US$ 6.2 Billion. Bioinformatics offers an indispensable technology for function assignment and it is widely used for gene annotation. With the increasing R&D investment by companies on bioinformatics and the regulatory support in various countries, we anticipate that the bioinformatics market will post high growth rate in majority of the countries.

At the country level, our study has found that the sales of bioinformatics in South Korea will grow at a CAGR of over 16% to US$ 270 Million by 2013. Other countries like India and the UK will also witness high growth rates in bioinformatics markets at a CAGR of approximately 9.5% and 16% respectively. Japan has demonstrated its capabilities as a global player in bioinformatics databases. Besides, the analysis software and services market for bioinformatics has registered a CAGR of more than 21% between 2007 and 2010.

We have found that the technology has its uses in a variety of areas, including Genomics, Proteomics, Pharmacogenomics and Cheminformatics. Our report provides the market size of these application areas for the past few years. Other research areas of bioinformatics like oncology are also highlighted in the report.

“Global Bioinformatics Market Outlook” provides extensive information and rational analysis of the global bioinformatics market and emerging trends. It gives an insight into the country trends and key market drivers to help clients with information that facilitates in taking prudent investment decision. The report also includes statistical analysis of different segments along with technological trends to give comprehensive overview of the market.